Skip to main content

axSpA: Impact of TNF and IL-17 in Patients with Prior TNF Exposure

Dr. Brian Jaros reviews abstract 1756,  presented at the 2024 ACR Convergence meeting in Washington, DC.

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×